Thrombin inhibition with inogatran for unstable angina pectoris: Evidence for reactivated ischaemia after cessation of short-term treatment

Coronary Artery Disease

Volumn 7, Issue 9, 1996, Pages 673-681

  Andersen, Karl ^a   Dellborg, Mikael ^a   Emanuelsson, Håkan ^a   Grip, Lars ^b   Swedberg, Karl ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ischaemia; thrombin inhibitor; unstable angina; vectorcardiography

Indexed keywords

INOGATRAN; THROMBIN INHIBITOR;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBIN TIME; UNSTABLE ANGINA PECTORIS;

EID: 0029857196     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199609000-00009     Document Type: Article

References (18)

1. Falk E: Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation 1985, 71:699-708.
2. Davies MJ, Thomas AC: Plaque fissuring - the cause of myocardial infarction, sudden ischaemic death and crescendo angina. Br Heart J 1985, 53:363-373.
3. Stein B, Fuster V, Israel DH, Cohen M, Badimon L, Badimon JJ, et al.: Platelet inhibitor agents in cardiovascular disease. An update. J Am Coll Cardiol 1989, 14:813-836.
4. Cunningham DD, Farrell DH: Thrombin interactions with cultured fibroblasts: relationship to mitogenic stimulation. Ann NY Acad Sci 1986, 485:240-248.
5. Théroux P, Waters D, Qui S, McCans J, de Guise P, Juneau M: Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation 1993, 88:2045-2048.
6. Théroux P, Ouimet H, McCans J, Latour J-G, Joly P, Levy G, et al.: Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988, 319:1105-1111.
7. Teger-Nilsson A-C, Eriksson U, Gustafsson D, Bylund R, Fager G, Held P: Phase I studies on inogatran, a new selective thrombin inhibitor [abstract]. J Am Coll Cardiol 1995, 117A-118A.
8. Gustafsson D, Elg M, Lenfors S, Börjesson I, Teger-Nilsson A-C: Effects of inogatran, a new low molecular weight thrombin inhibitor, on rat models of thrombosis [abstract]. Thromb Haemost 1995, 73:1319.
9. Dellborg M, Gustafsson G, Riha M, Swedberg K: Dynamic changes of the QRS-complex in unstable angina pectoris. Int J Cardiol 1992, 36:151-162.
10. Frank F: Accurate, clinically practical system for spatial vectorcardiography. Circulation 1956, 13:737-744.
11. Eisenberg PR, Sherman LA, Schectman K, Perez J, Sobel BE, Jaffe AS: Fibrinopeptide A: a marker of acute coronary thrombosis. Circulation 1985, 71:912-918.
12. Neri-Serneri GG, Gensini GF, Carnovali M, Frisco D, Rogasi PG, Casolo GC, et al.: Association between time of increased fibrinopeptide A levels in plasma and episodes of spontaneous angina: a controlled prospective study. Am Heart J 1987, 113:672-678.
13. Théroux P, Latour J-G, Léger-Gauthier C, de Lara J: Fibrinopeptide A and platelet factor levels in unstable angina pectoris. Circulation 1987, 75:156-162.
14. Merlini PA, Bauer KA, Oltrona L, Ardissino D, Cattaneo M, Belli C, et al.: Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 1994, 90:61-68.
15. Gold H, Torres FW, Garabedian HD, Werner W, Jang I-K, Kahn A, et al.: Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris. J Am Coll Cardiol 1993, 21:1039-1047.
16. FRISC Study Group: Low molecular weight heparin during instability in coronary artery disease. Lancet 1996, 347:561-568.
17. Théroux P, Waters D, Lam J, Juneau M, McCans J: Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med 1992, 327:141-145.
18. Granger CB, Miller JM, Bovill EG, Gruber A, Tracy RP, Krucoff MW, et al.: Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. Circulation 1995, 91:1929-1935.